Cloverfields Capital Group, LP Idexx Laboratories Inc Transaction History

Cloverfields Capital Group, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$391.37 - $557.56 $975,294 - $1.39 Million	-2,492 Reduced 54.34%	2,094 $1.16 Million
Q3 2023 Nov 14, 2023	BUY	$432.42 - $556.67 $134,050 - $172,567	310 Added 7.25%	4,586 $2.01 Million
Q2 2023 Aug 14, 2023	BUY	$450.7 - $503.61 $1.28 Million - $1.43 Million	2,845 Added 198.81%	4,276 $2.15 Million
Q1 2023 Sep 07, 2023	SELL	$406.01 - $514.59 $619,977 - $785,778	-1,527 Reduced 35.71%	2,749 $1.37 Million
Q1 2023 May 12, 2023	BUY	$406.01 - $514.59 $1,218 - $1,543	3 Added 0.21%	1,431 $715,000
Q4 2022 Feb 14, 2023	SELL	$324.64 - $441.27 $129,206 - $175,625	-398 Reduced 21.8%	1,428 $582,000
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $109,468 - $137,014	336 Added 22.55%	1,826 $595,000
Q1 2022 May 12, 2022	SELL	$466.52 - $631.01 $18,194 - $24,609	-39 Reduced 2.55%	1,490 $815,000
Q2 2021 Aug 12, 2021	BUY	$486.36 - $637.08 $8,268 - $10,830	17 Added 1.12%	1,529 $966,000
Q1 2021 May 13, 2021	SELL	$465.18 - $551.79 $91,175 - $108,150	-196 Reduced 11.48%	1,512 $740,000
Q4 2020 Feb 16, 2021	BUY	$383.85 - $499.87 $655,615 - $853,777	1,708 New	1,708 $854,000

1,194

73.5M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $35.1B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Cloverfields Capital Group, LP, based on Form 13F filings with the SEC.

Stay updated on Cloverfields Capital Group, LP with notifications on news.